Twitter-Delivered CME/CE on
Oncology from @onc_ce
Clinical trial data now exit the research facility and enter the practice landscape at unprecedented speed and volume, and the arrival of COVID-19 has not slowed this rapid flow of information. In fact, the pandemic has shifted the release of data to even more accessible digital formats. At this point, clinicians who manage cancer and who hope to stay current and apply new research to their daily practice cannot do so on their own; they benefit from an expert’s interpretation and distillation of data as they carry new information from conference to bedside. The need for distilled information presented in an applicable format has risen faster than ever.
The heterogeneity seen in various tissue tumor types reveals a need for ever-more individualized approaches that targets molecular subtype, genetic mutations, and immunological profile for each patient. Our accredited tweetorial feed, with each program authored by international experts, provides a forum for interaction, communication, and education for all healthcare providers with an interest in cancer.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Updates on GI Cancers: ASCO GI2022 and ASCO Plenary Session
1) Welcome to the next installment of our #accredited serialized #tweetorials from @onc_ce, your new (& only) home for the latest education from...
ASCO GI22 Update: Hepatobiliary Cancers
1) Welcome to the next installment of our key #oncology meeting highlights via #accredited #tweetorials from @onc_ce, your new (only) home for the...
Review of GIST and New Updates on Regorafenib
1) Welcome to the next installment of our #accredited serialized #tweetorials from @onc_ce, your new (& only) home for the latest education from...
ASCO #GI22: Gastric and esophageal cancers, HER2-targeted therapy, immunotherapy, ADCs
1) Welcome to the next installment of our key #oncology meeting highlights via #accredited #tweetorials from @onc_ce, your new (only) home for the...
Cancer-Associated VTE
2) ... one of the world's leading authorities on cancer-associated VTE as new faculty both here and on @cardiomet_ce: Dr. Alok Khorana @aakonc of...
SABCS: Advances in Management of TNBC
2) @Onc_ce and its companion website https://t.co/InvUb0xwNn are supported by educational grants from Astra Zeneca and Daiichi Sankyo and content is...
ER Positive Breast cancer, Advanced Stage
2) We continue to highlight the San Antonio Breast Cancer Symposium (#SABCS21), with more expert commentary for OUR #tweetorial followers! Our...
Early HR+ breast cancer, CDK4/6 inhibitors
2) Our second #tweetorial again comes from #SABCS21, which just wrapped up this month --only the most current updates for OUR followers! Our expert...
Antibody-drug Conjugates, HER2+ Breast Cancer, and HER2+ Brain Metastases
2) Our first #tweetorial comes from the San Antonio Breast Cancer Symposium (#SABCS21) which just wrapped up over the weekend--only the most current...
@ONC_CE on Twitter
Your only source for ACCREDITED SoMe-delivered serialized professional oncology education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @onc_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.